|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,959.50 GBX | -1.01% |
|
-2.22% | +7.40% |
| Jul. 09 | Gsk plc Announces Appointment of Roy Jakobs to Non-Executive Director, Effective July 13, 2026 | CI |
| Jul. 09 | Wall Street Ignores the Sirens |  |
| Market Cap | 78.08B 105B 91.51B 84.39B 148B 9,985B 151B 1,011B 396B 4,903B 393B 384B 16,984B | P/E 2026 * |
12.5x | P/E 2027 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 93.37B 125B 109B 101B 177B 11,940B 180B 1,209B 474B 5,864B 470B 459B 20,310B | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.54x |
| Free-Float |
92.29% | Yield 2026 * |
3.56% | Yield 2027 * | 3.74% |
Last Transcript: GSK plc
| Jul. 09 | GSK : Deutsche Bank remains Neutral | ZD |
| Jul. 09 | Computacenter gets two price target hikes | AN |
| Jul. 06 | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| Jul. 06 | HSBC raises GSK; RBC cuts Close Brothers | AN |
| Jun. 30 | UBS, RBC and Citi cut easyJet; UBS lowers Mondi | AN |
| 1 day | -1.01% | ||
| 1 week | -2.22% | ||
| Current month | -1.09% | ||
| 1 month | +2.94% | ||
| 3 months | -9.58% | ||
| 6 months | +3.90% | ||
| Current year | +7.40% |
| 1 week | 1,951 |  | 2,049 |
| 1 month | 1,906 | | 2,049 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
| Chief Tech/Sci/R&D Officer | - | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 68 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 21 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| Jun. 07 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| May. 21 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | -2.22% | +37.51% | +48.90% | 105B | |
| +0.09% | +0.25% | +54.65% | +169.19% | 1,084B | |
| -1.63% | -1.50% | +65.79% | +62.70% | 634B | |
| -1.12% | -4.27% | +31.10% | +84.44% | 447B | |
| +0.18% | -1.76% | +29.04% | +26.51% | 330B | |
| -6.22% | -8.14% | +28.87% | +32.09% | 295B | |
| -1.27% | -2.91% | +27.42% | +46.39% | 285B | |
| -0.93% | -3.57% | -27.74% | -40.38% | 218B | |
| -1.19% | -2.81% | +22.63% | +66.30% | 199B | |
| -0.72% | +2.72% | +19.07% | +81.19% | 169B | |
| Average | -1.25% | -1.36% | +28.84% | +57.73% | 376.53B | |
| Weighted average by Cap. | -0.91% | -1.21% | +38.88% | +83.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.37B 39.69B 36.6B 64.28B 4,331B 65.35B 438B 172B 2,127B 170B 167B 7,366B | 35.59B 47.68B 41.71B 38.47B 67.55B 4,551B 68.68B 461B 181B 2,235B 179B 175B 7,742B |
| Net income | 6.5B 8.71B 7.62B 7.03B 12.35B 832B 12.55B 84.19B 33B 408B 32.72B 32.01B 1,415B | 7.04B 9.43B 8.25B 7.61B 13.36B 900B 13.58B 91.08B 35.7B 442B 35.39B 34.63B 1,531B |
| Net Debt | 15.29B 20.49B 17.92B 16.53B 29.02B 1,956B 29.51B 198B 77.59B 960B 76.91B 75.25B 3,326B | 12.23B 16.39B 14.34B 13.22B 23.22B 1,564B 23.61B 158B 62.06B 768B 61.52B 60.19B 2,661B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | GBX 1,959.50 | -1.01% | 5,592,972 |
| 26-07-08 | GBX 1,979.50 | -1.17% | 4,243,789 |
| 26-07-07 | GBX 2,003.00 | +1.01% | 4,183,855 |
| 26-07-06 | GBX 1,983.00 | -1.59% | 15,158,597 |
| 26-07-03 | GBX 2,015.00 | +0.55% | 2,548,759 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
